Unexplained Infertility Epidemic: Missing Puzzle Piece Discovered

New testing methods for HHV-6A infections in the uterus are revolutionizing the fertility industry. Fertility Phoenix launched Coveetm, the missing puzzle piece in unexplained infertility. For the first time ever, there is an option to collect a sample from home and get answers directly, eliminating the need for uterine biopsies.

NEW YORK, April 2, 2024 /PRNewswire-PRWeb/ -- Fertility Phoenix launches Coveetm, an at-home kit that allows women to identify a specific link to infertility that the majority of the public do not know about yet.

"This is going to be huge! The beginning of a fertility care revolution, an opportunity to advance women's healthcare, and possibly the beginning of a do-it-yourself healthcare revolution," said Brenda Kate, CEO of Fertility Phoenix. "Coveetm empowers individuals to get answers about their fertility health, answers that aren't available at fertility clinics."

Designed for women who face challenges in conceiving or maintaining pregnancies, Coveetm offers a groundbreaking non-intrusive method to test for Human Herpesvirus 6A (HHV-6A), a significant but overlooked factor in unexplained infertility, recurrent pregnancy loss, and repeated implantation failures after IVF.

The launch of Coveetm is in response to a silent epidemic, with nearly 10 million women in the U.S. struggling to get pregnant or carry to term every year. "Coveetm is the first tangible tool against the deadliest virus in America, HHV-6A, which prevents 1.25 million births annually." added Daniel Knox, Director at Fertility Phoenix. "HHV-6A prevents more births than the number of deaths caused by heart disease, cancer, stroke, accidents, and covid-19."

Studies found that 43% of women with unexplained infertility tested positive for HHV-6A in their uterus, in stark contrast to 0% of fertile women. Research on treatment for HHV-6A further underscores it's significance in pregnancy outcomes. In one study, 42% of women diagnosed with unexplained infertility not only conceived following treatment for HHV-6A, but also carried their pregnancies to term, closely aligning with the 43% of unexplained infertility cases testing positive.

This information could help so many couples, and yet it is still in the dark. Everyone needs to know about HHV-6A and how it affects fertility.

"Coveetm won't help everyone with infertility, but imagine if it helped a million couples conceive per year. Within 20 years, or just a single generation, Coveetm will have empowered 60 million people." Director, Fertility Phoenix.

Coveetm is the first product of its kind accessible directly to consumers, and Fertility Phoenix envisions it as just the beginning of a wider array of home-based health checks, challenging the traditional healthcare model and empowering individuals to take control of their health from the comfort of their homes. By offering innovative solutions like Coveetm, Fertility Phoenix is setting a new standard in proactive fertility journeys.

"We are not a fertility clinic, we are connecting the proven science to the people, and reviving hope in the process." Brenda Kate, CEO at Fertility Phoenix.

Media Contact

Daniel Knox, Fertility Phoenix, 1 3025532643, [email protected], www.fertilityphoenix.com

SOURCE Fertility Phoenix